Table 2 Neonatal outcome in the two groups of neonates receiving and not receiving betamethasone
Characteristics | With betamethasone (n = 100) | Without betamethasone (n = 100) | P value | RR 95% CI |
|---|---|---|---|---|
TTN, % | 6 (6.0) | 3 (3.0) | 0.299 | 0.96 (0.91–1.02) |
Neonatal apnea, % | 2 (2.0) | 0 (0.0) | 0.153 | 0.98(0.95–1.00) |
NEC, % | 0 (0.0) | 0 (0.0) | N/A | N/A |
Neonatal sepsis, % | 37 (3.0) | 43 (43.0) | 0.418 | 0.86 (0.61–1.22) |
IVH, % | 20 (20.0) | 14 (14.0) | 0.245 | 1.42 (0.76–2.66) |
Hypoglycemia, % | 10 (10.0) | 10 (10.0) | 1.000 | 1.16(0.91–1.09) |
Neonatal resuscitation, % | 62 (62.0) | 53 (53.0) | 0.198 | 1.16(0.92–1.48) |
Respiratory support, % | 71 (71.0) | 50 (50.0) | 0.002 | 1.43 (1.13–1.80) |
Needing PPV, % | 31 (31.0) | 31 (31.0) | 1.000 | 1.01 (0.66–1.52) |
Needing CPAP, % | 37 (37.0) | 31 (31.0) | 0.343 | 1.20(0.81–1.77) |
Tracheal intubation, % | 6 (6.0) | 9 (9.0) | 0.432 | 0.66(0.24–1.80) |
RDS, % | 49 (49.0) | 31 (31.0) | 0.008 | 1.59(1.12–2.27) |
Needing surfactant use, % | 27 (27.0) | 19 (19.0) | 0.166 | 1.43(0.85–2.40) |
Asphyxia, % | 1 (1.0) | 0 (0.0) | 0.314 | 0.99(0.97–1.00) |
Length of hospital stay, day | 9.5 ± 1.2 | 9.8 ± 1.3 | 0.114 | N/A |
First minute Apgar | 7.0 ± 2.1 | 7.2 ± 1.9 | 0.092 | N/A |
Fifth minute Apgar | 8.7 ± 1.1 | 8.7 ± 1.2 | 0.644 | N/A |
Neonatal death, % | 3 (3.0) | 5 (5.0) | 0.470 | 0.60(0.14–2.44) |